Business
Apyx Medical Corporation Announces Launch of Renuvion® in China
Strong clinical interest and early procedures completed Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced the launch of Renuvion® in China as part of its international commercialization strategy. A targeted sales and marketing campaign for Renuvion is being conducted through a
About this update from Apyx Medical Corporation
[{"type":"image","alt":"Apyx Medical Corporation","displaySize":"","headline":null,"caption":"Apyx Medical Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WNW7RVUw1wUG.ea_dTVO0Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f776ee7f25241f6a4c93b21ba8aff893","width":300,"height":157}},"lazy":false},{"type":"text","content":"Strong clinical interest and early procedures completed","length":55,"tagName":"p"},{"type":"text","content":"Entered into distribution agreement with GlamMoon, a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance","length":133,"tagName":"p"},{"type":"text","content":"CLEARWATER, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced the launch of Renuvion® in China as part of its international commercialization strategy. A targeted sales and marketing campaign for Renuvion is being conducted through a distribution agreement covering China with GlamMoon Medical Technology, the wholly owned equipment distribution division of BeauCare Clinics Investment Co., Ltd. ("BCC"), a leading platform company in China’s medical aesthetics industry, following receipt of initial market clearance from the National Medical Products Administration of China.","length":664,"tagName":"p"},{"type":"text","content":"“The launch of Renuvion in China marks a significant milestone in our global expansion strategy,” said Charlie Goodwin, President and CEO of Apyx Medical Corporation. “We are proud to bring our innovative technology to one of the world’s largest and fastest-growing healthcare markets. The strong interest and initial sales we have seen underscore the unmet need Renuvion addresses, and we look forward to working with our partners to improve patient outcomes. These recent activities will help establish a commercial foundation which we will build upon through expanded regulatory approvals for Renuvion in China.”","length":615,"tagName":"p"},{"type":"text","content":"“We are excited to partner with Apyx Medical to bring this groundbreaking medical technology to the Chinese market,” said Ariel Liu, CEO of G...